Spotlight Therapeutics: Funding, Investors & Team (Oct 2026)
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.
Spotlight Therapeutics has raised $68.7M across 2 funding rounds on record, the most recent a Series B of $36.5M announced in Mar 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Spotlight Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2022.
Spotlight Therapeutics Funding Rounds
Spotlight Therapeutics raised $32.2M in an undisclosed round announced in Jan 2022.
2 months later, a Series B of $36.5M was announced in Mar 2022.
Spotlight Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Spotlight Therapeutics Funding Compared to Other Biotechnology Startups
Spotlight Therapeutics' latest round of $36.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Spotlight Therapeutics in Biotechnology and Hayward
Companies Similar to Spotlight Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Spotlight Therapeutics Funding FAQs
What does Spotlight Therapeutics do?
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.
How much funding has Spotlight Therapeutics raised?
Spotlight Therapeutics has raised $68.7M across 2 rounds on record. The most recent is a Series B of $36.5M announced in Mar 2022.
When did Spotlight Therapeutics last raise funding?
Spotlight Therapeutics' most recent funding round on record is a Series B of $36.5M, announced in Mar 2022.
Who is the CEO of Spotlight Therapeutics?
Mary Frendscho is listed as CEO at Spotlight Therapeutics.
Where is Spotlight Therapeutics headquartered?
Spotlight Therapeutics is based in Hayward, California, United States.
How many employees does Spotlight Therapeutics have?
Spotlight Therapeutics is in the 11-50 employee band.
How does Spotlight Therapeutics' funding compare to other Biotechnology startups?
Spotlight Therapeutics' latest round of $36.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Spotlight Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Spotlight Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.